Quick Dispatch:
Your soul trial oral semaglutide cardiovascular outcomes results 2024 2025 SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your soul trial oral semaglutide cardiovascular outcomes results 2024 2025 SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with ships.
Need Help?
Questions about soul trial oral semaglutide cardiovascular outcomes results 2024 2025 SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for soul trial oral semaglutide cardiovascular outcomes results 2024 2025 SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with in your area.
Updates in Medicine | 🩺 Oral Semaglutide Cuts CV Risk in High-Risk T2DM – SOUL Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹
21.49
Oral semaglutide found to lower risk of heart failure events in people with type 2 diabetes
24.74
SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with
21.88
SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes
22.14
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
24.81
Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial
27.80
Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease
27.97
